Profit Or Loss [Abstract]

Sopharma AD - Filing #6218824

Concept 2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
1,603,310,000 BGN
1,438,826,000 BGN
Cost of sales
1,166,508,000 BGN
1,041,687,000 BGN
Profit (loss) from operating activities
63,519,000 BGN
45,800,000 BGN
Finance income
6,632,000 BGN
5,081,000 BGN
Finance costs
11,797,000 BGN
19,099,000 BGN
Share of profit (loss) of associates and joint ventures accounted for using equity method
12,092,000 BGN
5,976,000 BGN
Profit (loss) before tax
97,574,000 BGN
31,442,000 BGN
Tax expense (income)
5,871,000 BGN
6,162,000 BGN
Profit (loss)
2,207,000 BGN
- BGN
- BGN
- BGN
89,496,000 BGN
- BGN
- BGN
- BGN
- BGN
91,703,000 BGN
89,496,000 BGN
25,280,000 BGN
- BGN
29,805,000 BGN
- BGN
- BGN
- BGN
- BGN
- BGN
4,525,000 BGN
29,805,000 BGN
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
89,496,000 BGN
29,805,000 BGN
Profit (loss), attributable to non-controlling interests
2,207,000 BGN
4,525,000 BGN
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share
0.71
0.24

Talk to a Data Expert

Have a question? We'll get back to you promptly.